Lumida
/ANAB
⌘K
AnaptysBio Inc

AnaptysBio Inc

ANAB
$58.00USD+7.11%+3.85 today

MARKET CAP

1.7B

P/E (TTM)

FWD P/E

DAY RANGE

$53 – $59

52W RANGE

$17
$73

AI Summary

Stalk
Sell NowMedium

ANAB remains in Stage 4 Decline with a decisive Support Failure and down-sloping EMAs confirming continued medium-term bearish bias; price sits below key moving averages with a recent rejection at the 9/20 EMA and 50 SMA zone, supporting immediate sell-side participation. Sell now into rallies.

  • $100M stock repurchase may boost share price amid undervaluation
  • Revenue of $25.6M topped expectations despite $1.84 EPS loss
  • EPS loss of $1.84 underscores weak profitability and cash burn
Full analysis →
Insider Trades42 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Mar 27, 2026SellANABDaniel FagaPresident, CEO17,679$61.61$1.7B-20.87%+239.06%$1.1M-0.35%Trim
Feb 11, 2026SellANABEric J LoumeauCHIEF LEGAL OFFICER20,000$41.85$1.7B-20.87%+239.06%$837.0K+0.00%10b5-1Trim
Jan 8, 2026SellANABEric J LoumeauCHIEF LEGAL OFFICER2,210$44.71$1.7B-20.87%+239.06%$98.8K-6.76%Trim
Jan 8, 2026SellANABDennis MulroyCHIEF FINANCIAL OFFICER2,515$44.71$1.7B-20.87%+239.06%$112.4K-5.66%Trim
Jan 8, 2026SellANABPaul F. LizzulChief Medical Officer3,650$44.71$1.7B-20.87%+239.06%$163.2K-5.12%Trim
Jan 8, 2026SellANABDaniel FagaPresident, CEO14,281$44.71$1.7B-20.87%+239.06%$638.5K-2.49%Trim
Jan 7, 2026SellANABDennis MulroyCHIEF FINANCIAL OFFICER1,908$45.11$1.7B-20.87%+239.06%$86.1K-2.54%Trim
Jan 7, 2026SellANABPaul F. LizzulChief Medical Officer2,235$45.11$1.7B-20.87%+239.06%$100.8K-2.33%Trim
Jan 7, 2026SellANABDaniel FagaPresident, CEO9,202$45.11$1.7B-20.87%+239.06%$415.1K-1.27%Trim
Jan 7, 2026SellANABEric J LoumeauCHIEF LEGAL OFFICER9,639$45.56$1.7B-20.87%+239.06%$439.2K-9.40%10b5-1Trim
Jan 5, 2026SellANABEric J LoumeauCHIEF LEGAL OFFICER2,983$43.26$1.7B-20.87%+239.06%$129.0K-9.68%Trim
Jan 5, 2026SellANABDennis MulroyCHIEF FINANCIAL OFFICER3,363$43.26$1.7B-20.87%+239.06%$145.5K-9.81%Trim
Jan 5, 2026SellANABPaul F. LizzulChief Medical Officer4,219$43.26$1.7B-20.87%+239.06%$182.5K-7.20%Trim
Jan 5, 2026SellANABDaniel FagaPresident, CEO15,309$43.26$1.7B-20.87%+239.06%$662.3K-2.82%Trim
Dec 22, 2025SellANABPaul F. LizzulChief Medical Officer3,000$34.25$1.7B-20.87%+239.06%$102.8K+0.00%10b5-1Trim
Dec 22, 2025SellANABEric J LoumeauCHIEF LEGAL OFFICER20,000$32.51$1.7B-20.87%+239.06%$650.2K+0.00%10b5-1Trim
Dec 22, 2025SellANABDennis MulroyCHIEF FINANCIAL OFFICER20,000$35.08$1.7B-20.87%+239.06%$701.6K+0.00%10b5-1Trim
Dec 16, 2025SellANABDennis MulroyCHIEF FINANCIAL OFFICER25,725$35.25$1.7B-20.87%+239.06%$906.9K-4.52%10b5-1Trim
Dec 16, 2025SellANABEric J LoumeauCHIEF LEGAL OFFICER45,141$30.77$1.7B-20.87%+239.06%$1.4M-0.07%10b5-1Trim
Sep 30, 2025SellANABEric J LoumeauCHIEF LEGAL OFFICER13,240$23.34$1.7B-20.87%+239.06%$309.1K-3.32%10b5-1Trim
Jan 3, 2025SellANABEric J LoumeauCHIEF LEGAL OFFICER5,211$14.90$1.7B-20.87%+239.06%$77.6K-3.54%Trim
Jan 3, 2025SellANABDennis MulroyCHIEF FINANCIAL OFFICER5,461$14.86$1.7B-20.87%+239.06%$81.2K-3.24%Trim
Jan 3, 2025SellANABPaul F. LizzulChief Medical Officer6,597$14.84$1.7B-20.87%+239.06%$97.9K-2.88%Trim
Jan 3, 2025SellANABDaniel FagaPresident, CEO19,420$14.83$1.7B-20.87%+239.06%$288.0K-1.35%Trim
Sep 23, 2024SellANABPaul F. LizzulChief Medical Officer3,000$28.59$1.7B-20.87%+239.06%$85.8K+0.00%10b5-1Trim
Sep 16, 2024SellANABPaul F. LizzulChief Medical Officer2,220$38.93$1.7B-20.87%+239.06%$86.4K-12.60%Trim
Sep 16, 2024SellANABEric J LoumeauCHIEF LEGAL OFFICER17,500$32.15$1.7B-20.87%+239.06%$562.6K-6.65%10b5-1Trim
Sep 16, 2024SellANABDennis MulroyCHIEF FINANCIAL OFFICER22,220$31.02$1.7B-20.87%+239.06%$689.3K-2.07%10b5-1Trim
Aug 14, 2024SellANABPaul F. LizzulChief Medical Officer4,000$29.25$1.7B-20.87%+239.06%$117.0K+0.00%10b5-1Trim
Jul 18, 2024SellANABPaul F. LizzulChief Medical Officer3,000$26.75$1.7B-20.87%+239.06%$80.3K+0.00%10b5-1Trim
May 22, 2024SellANABDennis MulroyCHIEF FINANCIAL OFFICER1,500$23.72$1.7B-20.87%+239.06%$35.6K-60.88%10b5-1Trim
Mar 22, 2024SellANABDaniel FagaCEO496,381$21.95$1.7B-20.87%+239.06%$10.9M-20.69%Trim
Feb 16, 2024SellANABEric J LoumeauCHIEF LEGAL OFFICER10,000$19.51$1.7B-20.87%+239.06%$195.1K+0.00%10b5-1Trim
Jan 30, 2024SellANABDennis MulroyCHIEF FINANCIAL OFFICER3,065$23.63$1.7B-20.87%+239.06%$72.4K-76.07%10b5-1Trim
Jan 8, 2024SellANABDennis MulroyChief Financial Officer2,180$21.81$1.7B-20.87%+239.06%$47.5K-9.93%Trim
Jan 8, 2024SellANABEric J LoumeauChief Legal Officer2,305$21.81$1.7B-20.87%+239.06%$50.3K-10.39%Trim
Jan 8, 2024SellANABPaul F. LizzulChief Medical Officer2,554$21.81$1.7B-20.87%+239.06%$55.7K-8.21%Trim
Jan 8, 2024SellANABDaniel FagaCEO6,866$21.81$1.7B-20.87%+239.06%$149.7K-0.72%Trim
Nov 22, 2023SellANABEric J LoumeauChief Legal Officer882$14.19$1.7B-20.87%+239.06%$12.5K-100.00%10b5-1Trim
Sep 14, 2023SellANABPaul F. LizzulChief Medical Officer2,105$19.48$1.7B-20.87%+239.06%$41.0K-14.39%Trim
Sep 14, 2023SellANABEric J LoumeauChief Legal Officer6,000$19.37$1.7B-20.87%+239.06%$116.2K-33.98%10b5-1Trim
Sep 14, 2023SellANABDennis MulroyChief Financial Officer6,000$19.37$1.7B-20.87%+239.06%$116.2K-33.66%10b5-1Trim